National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/12/2021 release of VAERS data:

Found 203 cases where Location is U.S., Territories, or Unknown and Vaccine is COVID19 and Manufacturer is JANSSEN and Symptom is Guillain-Barre syndrome

Government Disclaimer on use of this data



Case Details

This is page 15 out of 21

Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21   next


VAERS ID: 1628128 (history)  
Form: Version 2.0  
Age: 70.0  
Sex: Male  
Location: Colorado  
Vaccinated:2021-03-08
Onset:2021-03-22
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-08-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / IM

Administered by: Private       Purchased by: ?
Symptoms: CSF test abnormal, Electromyogram abnormal, Guillain-Barre syndrome, Nerve conduction studies
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: HTN, HLD
Allergies:
Diagnostic Lab Data: EMG/NCS 5/25/21 and CSF studies 6/11/21 supportive of GBS.
CDC Split Type:

Write-up: Patient developed likely Guillain Barre syndrome within a 2-3 weeks of getting his vaccine.


VAERS ID: 1631058 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-08-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Was there drug abuse or illicit drug usage? :: Unknown Does the patient consume alcohol? :: Unknown Does the patient smoke? :: Unknown
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210841025

Write-up: GUILLAIN-BARRE SYNDROME; This spontaneous report received from a patient via pharmaceutical company concerns a patient, sex, age, race, and ethnic origin not provided. The patient''s height, weight, and medical history was not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced Guillain-Barre syndrome. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of Guillain-Barre syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0: This spontaneous report received from a patient via pharmaceutical company concerns a patient of unknown age who experienced Guillain-Barre syndrome (GBS) unspecified time after vaccination. Patient past medical history , concomitant medications and concurrent medications were not reported. No other pertinent details reported. The information available precludes a complete and meaningful assessment . Information regarding other potential etiologies was insufficient, and the occurrence of GBS could represent background incidence of such events in the general population. Considering the temporal relationship, the event is assessed to have an indeterminate relationship with vaccination.


VAERS ID: 1631955 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Texas  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-08-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210843078

Write-up: GUILLIAN BARRE SYNDROME; This spontaneous report received from a consumer concerned 100 patients of unspecified age, sex, race and ethnicity. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced Guillain Barre syndrome. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of Guillain Barre syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0 : This spontaneous report was received from a consumer and concerned 100 people who experienced Guillain Barre syndrome (GBS) an unspecified period of time after receiving the Janssen Covid-19 vaccine. Medical history and concomitant medications were not reported. No other additional details regarding symptoms, diagnostics, treatment, or outcome were provided. Information is limited in this case, and the occurrence of GBS could represent background incidence of such events in the general population. Therefore, the relationship of GBS to vaccination is considered unclassifiable due to insufficient information. Additional information will be requested.


VAERS ID: 1638892 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: West Virginia  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-08-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood creatine phosphokinase, Blood folate, Blood glucose, Blood thyroid stimulating hormone, CSF cell count, CSF glucose, CSF protein, CSF test, Chest X-ray, Chills, Computerised tomogram head, Electromyogram, Fatigue, Fibrin D dimer, Gram stain, Guillain-Barre syndrome, HIV test, Liver function test, Magnetic resonance imaging, Magnetic resonance imaging head, Neurological examination, Pain in extremity, Physical examination, Red blood cell sedimentation rate, Renal function test, Vitamin B12, White blood cell count
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Morbid obesity; Comments: No significant medical history
Allergies:
Diagnostic Lab Data: Test Date: 20210820; Test Name: EMG; Result Unstructured Data: See Result Unstructured Data field; Test Name: MRI; Result Unstructured Data: See Result Unstructured Data field; Test Name: Neurological examination; Result Unstructured Data: See Result Unstructured Data field; Test Name: MRI; Result Unstructured Data: Cervical and thoracic: did not show any abnormal T2 signal changes; Test Name: MRI; Result Unstructured Data: lumbar: no significant degenerative disc disease; Test Name: CSF cell count; Result Unstructured Data: See Result Unstructured Data field; Test Name: CSF protein; Result Unstructured Data: 562 mg/dL; Test Name: CSF glucose; Result Unstructured Data: 67 mg/dL; Test Name: CSF gram stain; Result Unstructured Data: negative; Test Name: CSF test; Result Unstructured Data: See Result Unstructured Data field; Test Name: WBC count; Result Unstructured Data: 15.0 10*9/L; Test Name: Fibrin D dimer; Result Unstructured Data: borderline elevated; Test Name: Erythrocyte sedimentation rate; Result Unstructured Data: within normal values; Test Name: Creatine phosphokinase; Result Unstructured Data: within normal values; Test Name: Blood glucose; Result Unstructured Data: within normal values; Test Name: Liver function test; Result Unstructured Data: within normal values; Test Name: Renal function test; Result Unstructured Data: within normal values; Test Name: Vitamin B12; Result Unstructured Data: within normal values; Test Name: Folate; Result Unstructured Data: within normal values; Test Name: TSH; Result Unstructured Data: within normal values; Test Name: HIV test; Result Unstructured Data: Negative; Test Name: Chest X-ray; Result Unstructured Data: Unremarkable with no hilar or mediastinal lymphadenopathy.; Test Name: MRI brain; Result Unstructured Data: See Result Unstructured Data field; Test Name: Head CT; Result Unstructured Data: colloid cyst; Test Name: Physical examination; Result Unstructured Data: vital signs were stable
CDC Split Type: USJNJFOC20210837750

Write-up: BIFACIAL DIPLEGIA VARIANT OF GUILLIAN- BARRE SYNDROME; ARM SORENESS; CHILLS; MILD FATIGUE; This spontaneous report was received from literature: A Novel Case of Bifacial Diplegia Variant of Guillain-Barre Syndrome Following Janssen COVID-19 Vaccination. Neurology International. 2021 Aug 13; 13404-409. This report concerned a 41 year old male, race and ethnic origin not reported. The patient''s height, and weight were not reported. The patient''s concurrent conditions included: morbidly obese, with no significant medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, frequency 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. The patient presented to the emergency department (ED) with acute onset of urinary retention twelve days after vaccine administration. The patient only reported arm soreness, mild fatigue, and chills three days after the vaccination which were self-resolving in a few days. He underwent evaluation in the ED followed by urinary catheterization and was followed up with urology as an outpatient. On day 15 following his COVID-19 vaccination, he returned to the ED with a new onset of left-sided facial droop. He was diagnosed with Bell''s palsy and was discharged with prednisone and valacyclovir. His CT brain showed a colloid cyst and, hence, he was referred to see neurosurgeons as an outpatient. On day 21 post-vaccination, he presented to the ED with subjective weakness and paresthesias in all extremities. He had difficulty feeding himself and ambulating due to his weakness. He also had new onset of right facial weakness. His urinary retention had resolved. He denied any blurry vision, dysphagia, and headache. Upon physical examination, his vital signs were stable. Neurological examination, including a cranial nerve examination showed bilateral lower motor neuron facial nerve palsy, more prominent on the left compared to right. His deep tendon reflexes were absent bilaterally at the patella and the Achilles with mute plantar responses. Motor strength was 4+/5 (Medical Research Council grade) in all four extremities. An MRI of the cervical and thoracic spine did not show any abnormal T2 signal changes and his lumbar spine showed no significant degenerative disc disease. He underwent lumbar puncture due to suspicion for Guillain-Barre syndrome (GBS) and showed albumino-cytological dissociation with a CSF cell count of 50/uL (lymphocytes 91%, monocyte 9%, red blood cell counts of 123) and CSF protein of 562 mg/dL. Further corrected cerebrospinal fluid (CSF) protein for the presence of RBC was significantly elevated to 562 mg/dL. Other CSF findings included glucose of 67 mg/dL (serum glucose 109 mg/dL) and negative CSF gram stain, CSF lyme polymerase chain reaction (PCR), and viral PCR testing on CSF, including herpes simplex virus, varicella zoster virus, Epstein-Barr virus, cytomegalovirus (CMV) and Borrelia burgdorferi IgM and IgG. Given the classic clinical picture of GBS in absence of other identifiable etiology for his neurologic disease, additional supportive testing with EMG showed a prolonged distal latency with conduction block and slow conduction velocity in bilateral tibial, peroneal nerve, and absent F waves were supportive for demyelinating GBS. He was started on intravenous immunoglobulin (IVIG) at 2 g/kg over 5 days. Other notable laboratory findings included a white cell count of 15.0 10*9/L, possibly due to recent steroid use and borderline elevated D-dimer. The erythrocyte sedimentation rate, creatine phosphokinase, blood glucose, hepatic and renal function, vitamin B12, folate levels, and thyroid-stimulating hormones were all within normal values, whereas the serum HIV test was negative. Chest X ray was unremarkable with no hilar or mediastinal lymphadenopathy. Clinically, the patient showed significant improvement after the first dose of 400 mg/kg of IVIG. The patient strength was 5/5 in all muscle groups one day after IVIG treatment. He showed recurrence of his right patellar reflex on day 4 of IVIG treatment and trace right ankle reflex with continued absence of left patellar and ankle reflex. The patient finished 5 days of IVIG treatment with mild side-effects, including nausea and headache. It was reported the patient responded very well to IVIG treatment with improvement of his symptoms. He continued to be significantly ataxic and was intended to be placed in a rehabilitation facility. Patient followed in outpatient clinic had MRI imaging of brain showed incidental finding of colloid cyst, no facial nerve enhancement, no mass lesion, no abnormal leptomeningeal. Repeat MRI lumbar spine with contrast showed thickening of cauda equina nerve roots suggestive of inflammatory demyelinating neuropathy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from arm soreness, chills, and mild fatigue, and the outcome of bifacial diplegia variant of guillian- barre syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0: This 41-year-old male patient having morbid obesity with no other significant medical history, with incidental finding of Colloid brain cyst on CT brain, about 15 days after prophylactic vaccination and also experienced bifacial diplegia variant of Guillian-Barre syndrome(GB syndrome) within 3 weeks of vaccination. Initial symptom of acute onset of urinary retention started about 12 days after vaccination which was treated with catheterization. Later patient presented with new onset of left-sided facial droop and initial diagnosis made as Bell''s palsy and found to have colloid cyst in CT brain; treated with prednisone and valacyclovir. On day 21 post-vaccination, patient presented with weakness and paresthesias in all extremities, new onset of right facial weakness with neurological findings of bilateral lower motor neuron facial nerve palsy, more prominent on the left compared to right, deep tendon reflexes absent bilaterally at the patella and the Achilles with mute planter responses. Motor strength was 4+/5 in all four extremities. An MRI of cervical, thoracic and lumbar spine did not reveal any degenerative disease. CSF examination revealed albumin-cytological dissociation with CSF cell count of 50/uL and CSF protein of 562 mg/dL with negative CSF gram stain, CSF lyme polymerase chain reaction (PCR), and viral PCR testing on CSF, including herpes simplex virus, varicella zoster virus, Epstein-Barr virus, cytomegalovirus and Borrelia burgdorferi IgM and IgG; negative serum HIV test and chest X-ray unremarkable. Additional testing with EMG was supportive for demyelinating GB syndrome. Patient was treated with intravenous immunoglobulin over 5 days and responded well clinically. Considering the temporal relationship and lack of other reported potential etiologies, GB syndrome is assessed to have a plausible relationship with vaccination.


VAERS ID: 1641727 (history)  
Form: Version 2.0  
Age: 60.0  
Sex: Female  
Location: Arizona  
Vaccinated:2021-05-07
Onset:2021-05-12
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-08-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 204A21A / 1 - / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Angiogram cerebral normal, Arteriogram carotid normal, Cardiomegaly, Chest X-ray abnormal, Computerised tomogram head normal, Echocardiogram abnormal, Ejection fraction normal, Guillain-Barre syndrome, Intervertebral disc degeneration, Left ventricular dysfunction, Lumbar puncture normal, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal, Microangiopathy, Vertebral foraminal stenosis
SMQs:, Cardiac failure (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Cardiomyopathy (broad), Demyelination (narrow), Infective pneumonia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Primidone 50mg TID, Mirtazapine 45mg qhs, symbicort 160-4.5mcg/act aerosol prn, diclofenac sodium 75mg prn, omeprazole 20mg qd, certizine 10mg qd, levothyroxine 100mcg qd, losartan 50mgqd, ambien 10mg qgs
Current Illness: Essential tremor, HTN, Hyperlipidemia, asthma, depression, IBS, gerd
Preexisting Conditions: see above
Allergies: sulfa
Diagnostic Lab Data: CT brain (negative) 5/12/2021 XRay chest - mild cardiomegaly 5/12/2021 MRA Head w/o 5/12/2021: intact proximal anterior and posterior intracranial circulations without proximal high grade stenosis, major branch occlusions, saccular aneurysm, or evidence of arteriovenous malformation. MRA carotid w/o 5/12/2021: no hemodynamically significant stenosis or flow limiting dissection of the common carotid, internal carotid, or vertebral arteries of the neck. MRI brain w/wo (5/12/2021): mild appearing underlying chronic microangiopathic disease without acute or sizable chronic cortical infarct. No mass effect, hydrocephalus, intracranial hemorrhage, or convincing evidence of demyelinating disease. No abnormal intracranial enhancement. Echocardiogram with bubble study (5/13/21) EF 60%, grade 2 left ventricular diastolic dysfunction. Lumbar Puncture 5/14/2021: unsuccessful after two attempts. IR lumbar puncture 5/14/2021 : obtain 6ml bloodtinged CSF. - workup unremakable MRI c-spine w.o contrast 5/15/2021: normal signal intensity of spinal cord, mild cervical disc degneration greatest at C4-5 and C5-6, no central spinal canal stenosis, mild to moderate left neural foraminal narrowing at c7-t1.
CDC Split Type:

Write-up: Patient experienced Guillan Barre Syndrome/TIA on 5/12/2021 and was hospitalized at Deer Valley Medical Center (Honor Health) 5/12-5/15/2021


VAERS ID: 1653908 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Male  
Location: Minnesota  
Vaccinated:2021-08-12
Onset:2021-08-19
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-08-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 207A21A / 1 - / -

Administered by: Private       Purchased by: ?
Symptoms: CSF protein increased, CSF white blood cell count increased, Dissociation, Facial paresis, Guillain-Barre syndrome, Immunoglobulin therapy, Lumbar puncture abnormal, Paraesthesia
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Vitamin D3, Flaxseed, Zinc, ketorolac
Current Illness: None
Preexisting Conditions: None
Allergies: Shellfish allergy
Diagnostic Lab Data: Lumbar puncture performed 8/28 showed albuminocytologic dissociation with a protein count of 217 and a white count of 18. Starting on IVIG therapy on 8/28.
CDC Split Type:

Write-up: Ascending paresthesias and paralysis; started one week after vaccination in back and legs and by the time of presentation had ascending up to abdomen and bilateral arms, now with facial weakness.


VAERS ID: 1658107 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Male  
Location: Minnesota  
Vaccinated:2021-08-01
Onset:2021-08-20
   Days after vaccination:19
Submitted: 0000-00-00
Entered: 2021-08-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 207A21A / 1 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Blood test normal, Guillain-Barre syndrome, Laboratory test normal, Lumbar puncture abnormal, Pain, Pain in extremity
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Flax seed pills qty 2 each day
Current Illness: No
Preexisting Conditions: No
Allergies: She?ll fish
Diagnostic Lab Data: ER visit 8-26-2021 all blood test normal all other test normal. Urgent Care visit 8-27-2021 all blood test normal DR advised going back to ER for spinal test. ER visit 8-28-2021 spinal test came back positive Guillian-Barre.Admitted to Hospital for treatment and therapy
CDC Split Type:

Write-up: The pain started in both feet in a course of the week it move up his entire body .After two ER visits and One Urgent care we ask for a spinal test with results positive Guillian Barre.


VAERS ID: 1659117 (history)  
Form: Version 2.0  
Age: 51.0  
Sex: Male  
Location: California  
Vaccinated:2021-04-01
Onset:2021-05-01
   Days after vaccination:30
Submitted: 0000-00-00
Entered: 2021-08-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Electromyogram, Guillain-Barre syndrome, Lumbar puncture, Magnetic resonance imaging
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 20 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: Penicillin
Diagnostic Lab Data: MRI, LP, EMG
CDC Split Type:

Write-up: Pt developed severe Guillain Barre syndrome around 3 weeks after vaccine administration


VAERS ID: 1660323 (history)  
Form: Version 2.0  
Age: 53.0  
Sex: Female  
Location: New York  
Vaccinated:2021-04-02
Onset:2021-04-16
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-09-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Electromyogram, Guillain-Barre syndrome, Sensory loss
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Concerta, Latuda, Lamictal, Lexapro
Current Illness: Eczema
Preexisting Conditions: Eczema
Allergies: No
Diagnostic Lab Data: Office exam and an EMG diagnostic
CDC Split Type:

Write-up: Guillain-Barr? syndrome - left arm (vaccine given to right arm) Slight loss of sensitivity in left leg. Occured around 2 weeks after vaccine.


VAERS ID: 1660978 (history)  
Form: Version 2.0  
Age: 63.0  
Sex: Female  
Location: New Jersey  
Vaccinated:0000-00-00
Onset:2021-07-27
Submitted: 0000-00-00
Entered: 2021-09-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808986 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Computerised tomogram, Diarrhoea, Guillain-Barre syndrome, Lumbar puncture, Magnetic resonance imaging, Pain in extremity, Weight, Weight decreased
SMQs:, Peripheral neuropathy (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Pseudomembranous colitis (broad), Guillain-Barre syndrome (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Demyelination (narrow), Noninfectious diarrhoea (narrow), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 9 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: LOSARTAN POTASSIUM; VALTREX; DIAZEPAM
Current Illness: Abstains from alcohol; Hypertension; Marijuana abuse (On occasion); Smoker (One cigarette once a month; history of smoking)
Preexisting Conditions: Medical History/Concurrent Conditions: Vertigo; Comments: The patient was otherwise healthy.
Allergies:
Diagnostic Lab Data: Test Date: 202108; Test Name: MRI; Result Unstructured Data: Not reported; Test Date: 202108; Test Name: Weight; Result Unstructured Data: lost about 12 lbs; Test Date: 202108; Test Name: CT scan; Result Unstructured Data: Not reported; Test Date: 202108; Test Name: Spinal tap; Result Unstructured Data: Not reported
CDC Split Type: USJNJFOC20210858474

Write-up: GUILLAIN BARRE SYNDROME; LOST ABOUT 12 LBS; DIARRHOEA; SORE ARM; This spontaneous report received from a patient concerned a 63 year old White and non Hispanic or Latino female. The patient''s weight was 149 pounds, and height was 64 inches. The patient''s past medical history included: vertigo (rarely), and concurrent conditions included: hypertension, non alcoholic, smoker, and smokes marijuana, and other pre-existing medical conditions included: The patient was otherwise healthy. The patient experienced dry cough when treated with lisinopril. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986, expiry: UNKNOWN) dose was not reported, 1 total, administered on 27-JUL-2021 to left arm for prophylactic vaccination. Concomitant medications included diazepam, losartan potassium, and valaciclovir hydrochloride. On 27-JUL-2021, right after vaccination, the patient experienced a bit of sore arm, which lasted a couple of days. The patient could not remember exact date for rest of report, but it was started possibly around on 15-AUG-2021 or 16-AUG-2021. The patient''s feet started feeling strange, like pins and needles, and she was in a lot of pain. The patient had diarrhea three times. She went to the chiropractor because her back was bothering her. The patient could not endure the pain (started in the feet, then to legs, then to hips, and to upper back), so they went to Emergency room (ER) in the middle of the night. The ER gave her some pain medication (unspecified) and she left (not admitted). It was reported that two days later she was back in the ER, and was admitted for 9 days. In the hospital, she was diagnosed with Guillain barre syndrome (GBS). Advil did not help the pain at all. It was reported that the patient needed to move more slowly and was still in pain. The patient was going to see primary care physician (PCP) tomorrow for follow-up. There was no expiration date on vaccination card. The patient had lost about 12 lbs in the hospital. She did not have access to any of the hospital reports. The patient was admitted on 15-AUG-2021 or 16-AUG-2021 and was discharged on 25-AUG-2021. The patient had a nephrologist, neurologist; perform Magnetic resonance imaging (MRI), spinal taps, Computerized tomography (CT scan) scans. Laboratory data included: CT scan (NR: not provided) Not reported, MRI (NR: not provided) Not reported, and Spinal tap (NR: not provided) Not reported. Treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on JUL-2021, had not recovered from Guillain barre syndrome, and the outcome of lost about 12 lbs and diarrhoea was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender''s Comments: V0: 20210858474- COVID-19 VACCINE AD26.COV2.S- Lost about 12 lbs This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. 20210858474-COVID-19 VACCINE AD26.COV2.S -Guillain Barre Syndrome. This event is labeled per RSI and is therefore considered potentially related


Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=15&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19&VAXMAN=JANSSEN&STATE=NOTFR


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166